Completed NA INTERVENTIONAL 1-arm NCT04939506

COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana

COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in Southeastern Louisiana

Sponsor: Xavier University of Louisiana.

Conditions Covid19 Vaccine Hesitancy Vaccine Refusal

Interventions COVID-19 Vaccine Education at the Point of COVID-19 Testing

Updated 6 times since 2021 Last updated: Feb 21, 2024 Started: Sep 1, 2022 Primary completion: Nov 30, 2023 Completion: Jan 25, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Covid19 and Vaccine Hesitancy and is currently completed. Xavier University of Louisiana. leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2023 — Mar 2024 [monthly]

Recruiting NA
Jan 2023 — Jun 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Sep 2021 — Jan 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xavier University of Louisiana.

Data source: Xavier University of Louisiana.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Orleans, United States